New Alzheimer's drug shows promise in early safety trial
Symptom relief
Completed
This early-stage study tested the safety of a new drug called BMS-984923 in 51 healthy older adults and people with Alzheimer's disease. The goal was to see if the drug is safe and tolerable, and to understand how it works in the body. This is a first step toward possibly easing …
Phase: PHASE1 • Sponsor: Allyx Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 11:16 UTC